🔗 Share this article

Given that America proceeds with historic changes to its vaccine recommendations, one figure appears unexpectedly: Tracy Beth Høeg, a US-based sports medicine doctor and epidemiologist who rose to prominence by expressing skepticism about Covid vaccines throughout the pandemic and has focused upon potential fatalities after Covid immunization in her recent position at the Food and Drug Administration.

Planned Overhauls to Pediatric Immunization Schedule

Health officials had intended to announce major changes to the pediatric vaccination calendar earlier this month, bringing the US with the Danish national calendar, it is understood – a major change that would place the US out of step with many the global community with no evidence for public health gain. The announcement has been pushed back until the new year.

In place of the top vaccines chief, Dr. Høeg is set to address the audience at the meeting. She was recently named temporary leader of the FDA’s CDER, the fifth appointee to head the office this year.

Consolidating Power at the Agency

This interim role might represent a strengthened alliance between the pharmaceutical and biologics divisions as Høeg and Prasad consolidate power at the FDA – and it points to a renewed priority upon dismantling already-approved immunizations at the FDA.

Dr. Høeg has repeatedly called for halting specific pediatric vaccine recommendations in the US to become more like Denmark, a nation with comprehensive healthcare and a citizenry roughly the population of the state of Wisconsin.

In her initial public appearances, she has continued to focus on vaccines – usually the responsibility of Prasad, director of the FDA’s Center for Biologics Evaluation and Research (CBER) – rather than medication approval.

Doubts Over Background

Høeg has little discernible track record in medication creation, oversight or administrative roles, which has been standard for past leaders of the Center for Biologics Evaluation and Research. She has been employed at the FDA as a senior adviser to the FDA chief and the vaccine center since March.

“She doesn’t seem to have the necessary background” for leading the drug-regulation department, remarked Dr. Jonathan Howard. “She has not conducted a clinical trial. She lacks experience in leading a major agency. She is not an expert in industry regulation.”

Previous directors of the center would “be deeply familiar with legal statutes and the research of pharmaceutical innovation”, noted a former acting FDA commissioner. “Clearly, she has not acquired the kind of background that prior appointees who ran CBER have had.”

This division has an enormous range of responsibilities at the agency, Woodcock pointed out.

“Many people just zeroes in on the novel medication approvals, but the generic program authorizes thousands of off-brand pharmaceuticals. There is also a biosimilars division, non-prescription drug unit and so forth, and every single one need to be supervised,” Woodcock explained. “The area you neglect, that is the part that I always told people is going to come back to haunt you.”

Furthermore, a significant leadership component to the job, which supervises more than 5,000 staff members. “It is a huge management job, if you execute it properly,” Woodcock concluded.

Response and Controversial Programs

When asked about questions about Høeg’s qualifications and whether this selection represents greater collaboration among FDA leaders on immunizations, a representative responded that the “concerns stem from incorrect assumptions”.

“Her experience matches the duties of her job,” the official explained, citing the period Dr. Høeg spent advising the agency head on “pharmaceutical safety and approval science, including computational safety modeling and immunization monitoring”.

As the temporary head, Dr. Høeg inherits the agency head's new priority voucher program, a disputed expedited medication authorization process that reportedly concerned her predecessors. “By what process are these medications being chosen for this fast-track system? Who takes the choices?” Dr. Howard said. “There’s a lot of confidentiality going on at the FDA right now.”

Broadly speaking, he stated, “the FDA appears to be shifting towards more relaxed regulations of pharmaceuticals, aside from immunizations.”

Documented Past Work on Immunizations

Regarding vaccines, Dr. Høeg has a more established, if concerning, past, some experts said. She released a analysis using unconfirmed crowd-sourced reports to estimate the incidence of myocarditis following Covid immunization. She consulted for the Florida surgeon general Dr. Joseph Ladapo, who allegedly have modified findings to imply Covid vaccines are more dangerous than they are.

Included in her “desired changes” for the current administration encompassed altering regulations for new vaccines and ending “optional” vaccines, she said following the vote on a podcast. At the agency, Høeg has allegedly floated the idea of barring young men from receiving Covid vaccines.

“She’s an thorough ideologue who commences with her preconceived notions and works backwards to accommodate the science in a very deceptive, fraudulent way,” Dr. Howard argued.

Taking Control and a “Campaign of Retribution”

Dr. Høeg aligned with fellow skeptics, {like|